Chairs: Garry Cutting & Sir John Burn
HVP ICO contact: Amy McAllister
Creation date: 2010
Scope
The International Scientific Advisory Committee leads the Project in matters of strategic scientific direction for current and future activities. The International Scientific Advisory Committee is also responsible for oversseing the development and publication of all HVP Standards and Guidelines, as well as the arbitration of the dispute resolution process.
The International Scientific Advisory Committee meets on a face–to–face basis at least once per year, usually in conjunction with America Society of Human Genetics annual meeting, and monthly via teleconference.
Members
The voting members of the International Scientific Advisory Committee members are elected by the two Advisory Councils (six members from each Council) every two years, with half the positions on the Committee becoming vacant every two years. The Committee can co-opt as many non-voting individuals onto the Committe as it sees fit. The Chair of the International Scientific Advisory Committee is appointed from among the members of the International Scientific Advisory Committee. Voting membership of the Committee, in an ex-officio capacity, is also extended to:
- the Regional Scientific Directors of the Human Variome Project;
- the President of the Human Genome Variation Society;
- the President of the International Federation of Human Genetics Societies; and
- a representative from the central genetic databases, chosen from amongst themselves.
Any Individual Member of the Human Variome Project Consortium is eligible to stand for election to the International Scientific Advisory Committee. Candidates must be nominated and seconded by a member of either of the Advisory Councils.
Voting Members |
||||
| Sir John Burn (co-Chair) | Newcastle University |  |
UK | 2011 |
| Garry Cutting (co-Chair) | Johns Hopkins School of Medicine |  |
USA | 2013 |
| Raymond Dalgleish | University of Leicester | |
UK | 2013 |
| Jordan Lerner-Ellis | Mount Sinai Hospital |  |
Canada | 2013 |
| Finlay Macrae | The Royal Melbourne Hospital |  |
Australia | 2010 |
| Ming Qi | Zhejiang University Medical School |  |
China | 2012 |
| Raj Ramesar | University of Cape Town |  |
South Africa | 2013 |
| Juergen Reichardt | James Cook University | |
Australia | 2015 |
| Peter Taschner | Leiden University Medical Center |  |
The Netherlands | 2013 |
| Mauno Vihinen | Lund University |  |
Sweden | 2010 |
| Michael Watson | American College of Medical Genetics and Genomics | |
USA | 2013 |
| Martina Witsch-Baumgartner | Medizinische Universität Innsbruck |  |
Austria | 2013 |
Non-voting Members |
||||
| Arleen Auerbach | The Rockefeller University | |
USA | 2010 |
| Qasim Ayub | Wellcome Trust Sanger Institute | |
UK | 2014 |
| Mireille Claustres | IURC, Institut Universitaire Clinical Research |  |
France | 2010 |
| Collet Dandara | University of Cape Town | |
South Africa | 2014 |
| Johan T. den Dunnen | Leiden University Medical Center | |
The Netherlands | 2010 |
| Mona El-Ruby | National Research Centre |  |
Egypt | 2010 |
| Aída Falcón de Vargas | Venezuelan Central University |  |
Venezuela | 2010 |
| Marc Greenblatt (HGVS President) | University of Vermont | |
USA | 2010 |
| Ada Hamosh | McKusick-Nathans Institute for Genetic Medicine | |
USA | 2014 |
| Helena Kääriäinen (IFHGS President) | National Institute for Health and Welfare |  |
Finland | 2015 |
| Dhavendra Kumar | University Hospital of Wales | |
UK | 2014 |
| Rita Inés Noher de Halac | National University of Cordoba |  |
Argentina | 2014 |
| Heidi Rehm | Harvard Medical School | |
USA | 2014 |
| Augusto Rojas Martínez | Universidad Autónoma de Nuevo León |  |
Mexico | 2014 |
| Katsushi Tokunaga | University of Tokyo |  |
Japan | 2014 |
| Thomas Weber | Department of Veterans Affairs New York Harbor Healthcare System | |
USA | 2014 |
| Ingrid Winship | University of Melbourne | |
Australia | 2014 |
Former Members |
||||
| Richard Cotton | University of Melbourne | |
Australia | 2010-2014 |
| Stephen Lam | Hong Kong Department of Health |  |
Hong Kong | 2010-2014 |
| Donna Maglott | National Center for Biotechnology Information | |
USA | 2013-2015 |
| Yoichi Matsubara | Tohoku University School of Medicine | |
Japan | 2010-2012 |
| Gert-Jan van Ommen | Leiden University Medical Center | |
The Netherlands | 2010-2013 |
| David Rimoin | Cedars-Sinai | |
USA | 2010-2012 |
Meeting Calendar
Work Products
International Scientific Advisory Committee Work Products
Role & Responsibilities
International Scientific Advisory Committee members are likely to be affiliated with an array of international groups—diagnostic laboratories, government agencies, foundations, citizen groups, universities and other interested parties—that work cooperatively to establish and maintain standards, systems and infrastructure for the worldwide collection and sharing of all genetic variations effecting human disease. Established in 2010, the Committee oversees the Human Variome Project's scientific development, assists in recruiting new Human Variome Project partners, promotes the participation in and use of Human Variome Project at meetings and conferences, and recommends goals for the Project.
Each International Scientific Advisory Committee member is expected to:
- be fully versed in the goals and objectives of the Human Variome Project;
- actively participate in all Human Variome Project activities and events, including regular attendance at Advisory Committee meetings;
- serve on one or more Advisory Committee strategic planning groups (when requested or consistent with his/her area of expertise) to promote and stimulate specific aspects of Human Variome Project marketing or development;
- adhere to and assist in generating HVP Standards and Guidelines and educate others, as well as public and private organizations, about what it means to be a Human Variome Project participant;
- be accessible to Human Variome Project Coordinating Office staff for periodic inquiries concerning Human Variome Project business;
- work within his/her state, country or organization to secure in-kind services or related resources that may be required to address Human Variome Project priorities;
- maintain a proactive role in Human Variome Project operations, including provision of advice, support and feedback on all aspects of Human Variome Project activities, including content development, marketing and the application of new technologies;
- make suggestions to Human Variome Project Coordinating Office staff regarding ideas for projects, grant proposals and/or collaborations; and
- identify potential supporters for Human Variome Project.
